Shin YJ, Kim YJ, Lee JE, et al
PMID 12031810
Strategies under study to cross the BBB include viral vectors (257) as gene therapy delivery, enhancement of brain permeability (258), delivery through the pathologic permeable BBB, intranasal drug administration to bypass the BBB (259), nanoparticles (NPs) to actively target the brain, or delivery through active BBB transporters (39)
It is imperative that only qualified and licensed professionals handle this product
Multiple Dose Vials for Flexible Dosing Each tray contains 25 vials (200 mg B1/2 mL each), perfect for hospitals, clinics, and ongoing patient care
Shelf Life After Reconstitution (Solution Form) Once BPC-157 has been reconstituted (i.e., mixed with a solvent such as bacteriostatic water or saline) the stability drops because the peptide is now in aqueous solution, exposed to possible hydrolysis, oxidation, microbial growth, aggregation